share_log
Reuters ·  Jul 2 16:05
Gyre Therapeutics Announces China’s Nmpa Approval of Avatrombopag Maleate Tablets for the Treatment of Cld-Associated Thrombocytopenia
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment